WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 249

Legislative bill overview

SB 249 would allow ivermectin, an antiparasitic medication, to be dispensed without a prescription in Ohio. The bill removes the current requirement for medical supervision before obtaining this drug, making it available over-the-counter or through pharmacist dispensing without doctor approval.

Why is this important

Ivermectin's regulatory status has become contentious due to its use as an unapproved COVID-19 treatment during the pandemic. This bill reflects broader debates about medical autonomy, pharmaceutical access, and the role of prescriptions in drug safety. The policy could affect how Ohioans access medication and influence similar proposals in other states.

Potential points of contention

  • Safety concerns: Ivermectin requires dosing adjustments based on patient weight, medical conditions, and drug interactions. Without prescriber oversight, risks of overdose, organ damage, and adverse interactions increase, particularly for vulnerable populations.
  • Misuse for unapproved conditions: The bill may facilitate use of ivermectin for COVID-19 and other conditions lacking FDA approval, despite clinical evidence showing minimal or no benefit and potential harms.
  • Pharmacy burden: Pharmacists would assume greater liability for counseling and screening without standardized protocols, potentially creating inconsistent safety practices across providers.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.